4th Quarter - Report

MEDCO HEALTH SOLUTIONS, INC for MEDCO HEALTH SOLUTIONS INC

Firm
Client
Income
—
Expenses
$760,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory policies related to health reform implementation: structure, drug benefits, disclosure; Regulatory implementation of HITECH, Medicare Part-D, Accounting of Disclosures; FDA issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs)

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
DOLLY JUDGE New —
RYAN SADLER —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D; healthcare regulations; closing of the Part D coverage gap; proposed antitrust exemptions for certain pharmacies; IVIG payment structure; Medicare demonstration projects for durable medical equipment; home infusion; PBM disclosure provisions; increasing healthcare value; competitive bidding (H.R. 2195, S. 1203, H.R. 1845, S. 960, H.R. 979, H.R. 1041)

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
DOLLY JUDGE New —
RYAN SADLER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1845 (112th), S. 960 (112th), S. 1203 (112th), H.R. 979 (112th), H.R. 1041 (112th), H.R. 2195 (112th)

Pharmacy PHA

Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (EHB, grandfathering, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway to approve biosimilars; REMs; 340b program

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
DOLLY JUDGE New —
RYAN SADLER —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 27 (112th)

Postal POS

Legislation related to mail delivery frequency (The Postal Reform Act; U.S. Postal Service Improvements Act; Postal Operations Sustainment and Transformation Act; and Reform the Postal Service for the 21st Century Act)

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —

Contacted: SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from antitrust laws for purposes of negotiating with payers (H.R. 1409, H.R. 1946, H.R. 1839). Advocacy surrounding proposed corporate merger.

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
DOLLY JUDGE New —
RYAN SADLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: H.R. 1409 (112th), H.R. 1946 (112th), H.R. 1839 (112th)

Affiliated organisations

OrganisationLocation
ACCREDO HEALTH GROUP, INC. Memphis, TN, US
LIBERTY MEDICAL SUPPLY, INC. Port St. Lucie, FL, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.